Markets · Global Equities · US
ABVC BIOPHARMA, INC. ABVC
Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.
- Revenue TTM 1.30M
- EBITDA TTM -5.78M
- Net debt 89498.0
- ND/EBITDA -0.02
- EBITDA/interest -22.9
- ROE -0.56
- Implied band BB